Nasjonal Beredskapsplan Pandemisk Influensa

Objectives

Norway’s national pandemic influenza preparedness plan provides a cross-sector framework to prevent and limit transmission, illness and deaths; sustain health services and essential societal functions; and maintain public confidence through coordinated, evidence-based information.[1][2]It applies to health authorities and providers, all ministries and their sectors, and Norwegian foreign missions.[3]

• Organise preparedness and response around World Health Organization pandemic phases, while allowing national measures to reflect Norway’s local epidemiological, virological and clinical situation rather than global phase declarations alone.[4][5]
• Cover planning and coordination, surveillance and assessment, prevention and containment, response, and communication through a phased action plan supported by technical material.[1][6]
• Prevent illness and deaths through general infection-control measures, vaccination, antiviral treatment and appropriate patient care, with vaccination intended as the principal pandemic-control measure once available.[7][2]
• Maintain essential functions, including health and care services, education, transport, telecommunications, energy, water supply and wastewater services, during significant workforce absence and service disruption.[8][9]
• Prepare for uncertain and variable pandemic scenarios, adjusting measures to transmission, severity, affected groups, mortality, vaccine availability and health-service capacity.[9][10]
• Apply ethical prioritisation based on expected benefit, severity, proportionality, fairness, solidarity, equal human worth and public trust, rather than age alone.[11][12]
• Prioritise initially scarce vaccines and antivirals for healthcare personnel, personnel sustaining essential societal functions, and people at increased risk of severe illness or death, with priorities subject to reassessment as evidence develops.[13][14][15]
• Use surveillance to detect and characterise outbreaks, assess disease burden and severity, monitor vaccine coverage and adverse events, and support timely adaptation of interventions.[16][17][18]

Implementation

Implementation relies on existing statutory responsibilities, emergency plans, notification systems and service-delivery arrangements, adapted for pandemic conditions.[7]The Ministry of Health and Care Services holds overall health-sector preparedness responsibility, while ministries and organisations retain responsibility for their own sectors and operational plans.[19][2]

• Coordinate central crisis management through a lead ministry, the Crisis Council and the Crisis Support Unit; the Ministry of Justice and Public Security is the permanent lead ministry for civilian national crises unless another arrangement is decided.[20][21]
• Assign the Ministry of Health and Care Services responsibility for national pandemic-phase transitions and, where appropriate, delegate crisis management and phase decisions to the Norwegian Directorate of Health.[5][22]
• Require municipalities, regional health authorities, health enterprises and other actors to maintain, exercise, review and update preparedness plans, with clear roles, reporting lines, activation procedures and cooperation across primary and specialist care.[1][23][24]
• Use municipalities for local infection-control work, epidemiological oversight, public advice, preventive measures and local vaccination delivery, led professionally by the municipal medical officer.[25][26]
• Coordinate national infectious-disease response through the Directorate of Health in close cooperation with the Norwegian Institute of Public Health and, where relevant, the Norwegian Food Safety Authority.[27]The Institute manages epidemiological surveillance, vaccine preparedness, influenza-virus monitoring and international disease-notification functions.[28][29]
• Use the Pandemic Committee as an advisory body for the Directorate of Health and the Institute of Public Health, including during plan revision and before, during and after a pandemic.[30]
• Deliver surveillance through clinical, virological, seroepidemiological and vaccination-register data, drawing on sentinel general practices, laboratories, hospitals, the national influenza centre and SYSVAK, the Norwegian Immunisation Registry.[17][18]
• Report surveillance information nationally and internationally each week during relevant periods, intensify reporting and diagnostic capacity when rapid information is needed, and adapt testing priorities as widespread transmission develops.[17][18][31]
• Maintain national preparedness stocks and supply arrangements for antivirals, vaccines, medicines, protective equipment, consumables and diagnostics, while using ordinary wholesaler and pharmacy networks for medicine distribution where possible.[32][33][34]
• Procure and distribute pandemic vaccine centrally through the Norwegian Institute of Public Health, while municipalities and health enterprises prepare to receive consignments and vaccinate priority groups, staff, inpatients and local populations.[35][26]
• Register pandemic vaccinations in SYSVAK to monitor individual status, population coverage, effectiveness and suspected adverse effects; complement spontaneous adverse-reaction reporting with linkage to other health registers.[36][37][11]
• Provide coordinated crisis communication through the Ministry of Health and Care Services, the Directorate of Health and responsible sector bodies, using Helsenorge.no as a principal shared channel alongside local, regional and national channels.[38]
• Cooperate internationally through the World Health Organization, European Union and European Economic Area mechanisms, Nordic preparedness arrangements and the International Health Regulations, including mutual information exchange, surveillance, notification and assistance.[39][40][41]
• Use exercises, regular plan reviews, risk assessments and post-incident learning to test notification, reporting and communication arrangements and improve preparedness.[2][3][42]

Monitoring & Evaluation

The plan establishes a phased monitoring, surveillance and assessment system for pandemic influenza, linking national decisions to the evolving epidemiological, virological and clinical situation rather than to World Health Organization phase labels alone. It combines human and animal surveillance, laboratory diagnosis, vaccination monitoring, health-service capacity assessment, risk assessment, notification, reporting, exercises and post-event learning.[4][5][43][17]

• Maintain integrated surveillance using clinical reports, virological testing, hospital admissions, influenza-related deaths, seroepidemiological studies, vaccine distribution and coverage, and adverse-event data.[17][18]
• Use sentinel general practices, medical microbiology laboratories, hospitals and the Norwegian Institute of Public Health’s national influenza centre to detect new viruses, characterise strains, test resistance and monitor geographical spread.[17][18][31]
• Report national and international influenza surveillance information weekly, including publication of weekly national updates and international situation reports.[17][18]
• Monitor vaccination coverage continuously through the Norwegian Immunisation Registry, SYSVAK, and use comprehensive vaccination registration to support assessment of vaccine effectiveness and adverse effects.[17][36]
• Investigate serious suspected vaccine reactions through spontaneous reporting, international adverse-reaction databases and rapid linkage between SYSVAK and other health registers.[37][11]
• Assess severity repeatedly using transmissibility, clinical attack rates, mortality, hospital and intensive-care admissions, affected age groups, resource pressure and the effectiveness of interventions.[44][6][43][45]
• Revise case definitions, surveillance arrangements and testing priorities as transmission becomes established, while retaining sentinel sampling to monitor viral changes and epidemic spread.[31][45]
• Notify suspected and confirmed cases promptly through national infectious-disease and veterinary channels, with statutory international reporting under the International Health Regulations where an event may constitute a serious international public-health event.[46][47][43]
• Assess events in Norwegian territory within 48 hours and notify the World Health Organization no later than 24 hours after assessment where the event may constitute a serious international public-health event.[46][47]
• Use the Norwegian Institute of Public Health to monitor outbreaks and determine the national epidemic stage in collaboration with national and international bodies, with the Ministry of Health and Care Services responsible for national phase transitions unless authority is delegated.[5][22]
• Test plans, notification lines and communication channels through exercises, require regular review and updating of preparedness plans, and incorporate lessons from incidents and exercises through systematic improvement work.[2][3]
• Conduct annual review of the pandemic planning framework through the Pandemic Committee and report results to the health ministry.[42]
• Evaluate implemented measures, treatment, vaccine effectiveness and safety, antiviral resistance, vaccination coverage, communication activities and the wider consequences of disease spread and control measures after waves and after the pandemic.[48][45][49][50]
• Apply accountability through statutory oversight by the Norwegian Board of Health Supervision, municipal and county health overviews, reporting by county governors, and role-specific responsibility for preparedness plans.[51][19][29]

The material provides numerous operational measures and data sources, but does not set out a single consolidated quantitative performance-indicator framework, universal reporting timetable or independent evaluation mechanism for the full plan.[42][52][53]

Costing & Financing

The plan identifies substantial preparedness-resource requirements, including medicines, vaccines, laboratory diagnostics, protective equipment, health-service capacity, staffing and stock management, but it provides no overall budget, costed implementation plan, funding-gap estimate or quantified national financing allocation.[42][43][32]

• Maintain national preparedness stocks of antivirals, vaccines, medicines, medical equipment, protective equipment, consumables and laboratory diagnostics, with stock composition and scale subject to continuing review.[42][32][33]
• Assign responsibility for the national antiviral emergency stock to the Directorate of Health and for national vaccine preparedness and vaccines to the Norwegian Institute of Public Health.[33]
• Secure access to pandemic vaccine for the whole population through procurement arrangements, while determining quantities, target groups and distribution priorities according to the severity and characteristics of the pandemic.[32][35][26]
• Plan for resource pressure on treatment capacity, intensive-care beds, ventilators, extracorporeal membrane oxygenation equipment, laboratories, surveillance systems, medicines, equipment and qualified personnel during severe scenarios.[44][11]
• Assess and mobilise additional human and material resources, alongside any necessary crisis-related legal powers, if Norway is affected.[54][43]
• Calculate resource needs for possible subsequent waves and assess stocks of antivirals, personal protective equipment and other medical equipment.[55][56]
• Use advance agreements with wholesalers, pharmacy owners and pharmacy-software providers to define service prices, compensation, traceability, reimbursement and potential patient charges for antiviral distribution.[34]
• Permit medicines or vaccines to be provided free of charge to people at risk or infected where the competent ministry so decides, while retaining arrangements capable of administering patient charges when applicable.[34][36]
• Recognise that vaccinators may charge a standard fee for each vaccination, although the source does not determine whether patients or the public sector bear this cost.[36]
• Support World Health Organization preparedness through financial contributions from organisations, including vaccine manufacturers, that receive pandemic-potential influenza viruses under the Pandemic Influenza Preparedness Framework.[57]
• Consider economic compensation for animal culling to improve compliance, without specifying an amount, allocation or funding source.[54]

Economic assumptions are mostly qualitative. The plan notes that general hygiene information is comparatively inexpensive, whereas population-wide activity restrictions, border closures, quarantine and mass traveller screening may impose substantial costs or resource demands with limited benefit.[58][59]It also anticipates that generic competition following expiry of the oseltamivir patent in 2016 could substantially reduce prices, without providing a monetary estimate.[60][61]